Center for Orphan Drug Research, University of Minnesota, Minneapolis, MN, USA.
Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
Epilepsia. 2018 Oct;59 Suppl 2:207-215. doi: 10.1111/epi.14479. Epub 2018 Aug 29.
A subgroup of patients with drug-resistant epilepsy have seizure clusters, which are a part of the continuum of seizure emergencies that includes prolonged episodes and status epilepticus. When the patient or caregiver can identify the beginning of a cluster, the condition is amenable to certain treatments, an approach known as rescue therapy. Intravenous drug administration offers the fastest onset of action, but this route is usually not an option because most seizure clusters occur outside of a medical facility. Alternate routes of administration have been used or are proposed including rectal, buccal, intrapulmonary, subcutaneous, intramuscular, and intranasal. The objective of this narrative review is to describe the (1) anatomical, physiologic, and drug physicochemical properties that need to be considered when developing therapies for seizure emergencies and (2) products currently in development. New therapies must consider parameters of Fick's law such as absorptive surface area, blood flow, membrane thickness, and lipid solubility, because these factors affect both rate and extend of absorption. For example, the lung has a 50 000-fold greater absorptive surface area than that associated with a subcutaneous injection. Lipid solubility is a physicochemical property that influences the absorption rate of small molecule drugs. Among drugs currently used or under development for rescue therapy, allopregnanolone has the greatest lipid solubility at physiologic pH, followed by propofol, midazolam, diazepam, lorazepam, alprazolam, and brivaracetam. However, greater lipid solubility correlates with lower water solubility, complicating formulation of rescue therapies. One approach to overcoming poor aqueous solubility involves the use of a water-soluble prodrug coadministered with a converting enzyme, which is being explored for the intranasal delivery of diazepam. With advances in seizure prediction technology and the development of drug delivery systems that provide rapid onset of effect, rescue therapies may prevent the occurrence of seizures, thus greatly improving the management of epilepsy.
耐药性癫痫患者中有一部分会出现癫痫发作群,这是癫痫急症连续谱的一部分,包括发作持续时间延长和癫痫持续状态。当患者或护理人员能够识别发作群的开始时,这种情况可以采用某些治疗方法,这种方法称为抢救治疗。静脉内药物给药可提供最快的起效速度,但该途径通常不是一种选择,因为大多数癫痫发作群发生在医疗机构之外。已经使用或提议使用替代给药途径,包括直肠、颊、肺内、皮下、肌肉内和鼻内。本叙述性综述的目的是描述:(1) 开发癫痫急症治疗方法时需要考虑的解剖、生理和药物物理化学特性;(2) 目前正在开发的产品。新疗法必须考虑到菲克定律的参数,如吸收表面积、血流量、膜厚度和脂溶性,因为这些因素会影响吸收的速度和程度。例如,肺的吸收表面积比皮下注射的吸收表面积大 50000 倍。脂溶性是影响小分子药物吸收速度的物理化学特性。在目前用于或正在开发用于抢救治疗的药物中,孕烷二醇具有最大的生理 pH 下的脂溶性,其次是异丙酚、咪达唑仑、地西泮、劳拉西泮、阿普唑仑和布瓦西坦。然而,脂溶性越大,水溶性越低,这使得抢救治疗的制剂复杂化。克服水溶性差的一种方法是使用水溶性前药与转化酶共同给药,这正在探索用于鼻内递送地西泮。随着癫痫发作预测技术的进步和提供快速起效的药物递送系统的发展,抢救治疗可能会预防癫痫发作的发生,从而极大地改善癫痫的管理。